Home »
1997 Issues »
62 FR (10/09/1997) » X97-21009. Antibiotic Drugs; Loracarbef, Loracarbef Capsules, and Loracarbef for Oral Suspension and Rifabutin and Rifabutin Capsules
X97-21009. Antibiotic Drugs; Loracarbef, Loracarbef Capsules, and Loracarbef for Oral Suspension and Rifabutin and Rifabutin Capsules
[Federal Register Volume 62, Number 196 (Thursday, October 9, 1997)]
[Rules and Regulations]
[Page 52659]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: X97-21009]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
21 CFR Part 436
Antibiotic Drugs; Loracarbef, Loracarbef Capsules, and Loracarbef
for Oral Suspension and Rifabutin and Rifabutin Capsules
CFR Correction
In Title 21 of the Code of Federal Regulations, parts 300 to 499,
revised as of April 1, 1997, on page 399, in Sec. 436.215(c)(16)(iv),
make the following changes:
1. Immediately following the equation, insert the word ``where:''
as a separate line.
2. In the second column, delete the hyphen between the words
``milligrams'' and ``per'' in line 2.
3. In paragraph (c)(18)(iv) of Sec. 436.215, immediately following
the equation, insert the word ``where:'' as a separate line.
BILLING CODE 1505-01-D
Document Information
- Published:
- 10/09/1997
- Department:
- Food and Drug Administration
- Entry Type:
- Rule
- Document Number:
- X97-21009
- Pages:
- 52659-52659 (1 pages)
- PDF File:
-
x97-21009.pdf
- CFR: (1)
- 21 CFR 436